Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes

被引:60
作者
Serradeil-Le Gal, C
Lafontan, M
Raufaste, D
Marchand, J
Pouzet, B
Casellas, P
Pascal, M
Maffrand, JP
Le Fur, G
机构
[1] Sanofi Synthelabo, F-31036 Toulouse 05, France
[2] CHU Rangueil, Inst L Bugnard, INSERM, U317, F-31054 Toulouse, France
[3] Sanofi Synthelabo, F-34184 Montpellier 04, France
关键词
neuropeptide Y; peptide YY; human adipocyte; lipolysis; neuropeptide YY1 receptor; leptin;
D O I
10.1016/S0014-5793(00)01649-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to characterize neuropeptide Y (NPY) receptors present in human adipocytes, we used selective ligands together with specific molecular probes able to recognize the different NPY receptor subtypes, RT-PCR experiments revealed the presence of Y-1 receptor transcripts with Y-4 and Y-5 and absence of Y-2 signals. Binding studies, using selective radioiodinated ligands, detected a high number (B-max = 497 +/- 124 fmol/mg protein) of a high affinity binding site only with [I-125]peptide YY (PYY) and [I-125](Leu(31),Pro(34))PYY. These sites exhibited a typical Y-1 profile as indicated by the rank order of affinity of SPY analogs and the high affinity of two selective NPY receptor antagonists, SR120819A and BIBP3226, In (S-35]GTP gamma S binding experiments, PW activation was totally inhibited by SR120819A and BIBP3226, Both compounds antagonized, with similar efficiency, the antilipolytic effect exerted by NPY in isolated adipocytes. Finally, PYY and Y-1 ligands enhanced adipocyte leptin secretion, an effect totally prevented by SR120819A, Thus, highly expressed in human adipocytes, the Y-1 receptor sustains the strong antilipolytic effect of NPY and exerts a positive action on leptin secretion. (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:150 / 156
页数:7
相关论文
共 22 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]   RADIOMETRIC ASSAYS FOR GLYCEROL, GLUCOSE, AND GLYCOGEN [J].
BRADLEY, DC ;
KASLOW, HR .
ANALYTICAL BIOCHEMISTRY, 1989, 180 (01) :11-16
[3]   DISTRIBUTION OF PYY RECEPTORS IN HUMAN FAT-CELLS - AN ANTILIPOLYTIC SYSTEM ALONGSIDE THE ALPHA(2)-ADRENERGIC SYSTEM [J].
CASTAN, I ;
VALET, P ;
LARROUY, D ;
VOISIN, T ;
REMAURY, A ;
DAVIAUD, D ;
LABURTHE, M ;
LAFONTAN, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (01) :E74-E80
[4]   IDENTIFICATION AND FUNCTIONAL-STUDIES OF A SPECIFIC PEPTIDE YY-PREFERRING RECEPTOR IN DOG ADIPOCYTES [J].
CASTAN, I ;
VALET, P ;
VOISIN, T ;
QUIDEAU, N ;
LABURTHE, M ;
LAFONTAN, M .
ENDOCRINOLOGY, 1992, 131 (04) :1970-1976
[5]   DIFFERENT NEUROPEPTIDE-Y RECEPTOR SUBTYPES IN RAT AND RABBIT VAS-DEFERENS [J].
DOODS, HN ;
KRAUSE, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 204 (01) :101-103
[6]  
Dumont Y, 1998, J COMP NEUROL, V402, P372
[7]   EXPRESSION OF CENTRAL AND PERIPHERAL CANNABINOID RECEPTORS IN HUMAN IMMUNE TISSUES AND LEUKOCYTE SUBPOPULATIONS [J].
GALIEGUE, S ;
MARY, S ;
MARCHAND, J ;
DUSSOSSOY, D ;
CARRIERE, D ;
CARAYON, P ;
BOUABOULA, M ;
SHIRE, D ;
LEFUR, G ;
CASELLAS, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 232 (01) :54-61
[8]   The beta(3)-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes [J].
Gettys, TW ;
Harkness, PJ ;
Watson, PM .
ENDOCRINOLOGY, 1996, 137 (09) :4054-4057
[9]  
HALVORSEN YDC, 1999, STRATEGIES, V11, P58
[10]   Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats [J].
Labelle, M ;
Boulanger, Y ;
Fournier, A ;
Pierre, SS ;
Savard, R .
PEPTIDES, 1997, 18 (06) :801-808